Search
for
Sort by
Research 31–60 of 1000+
- Lepidoptera Lexicon: Metaphorical Descriptors in Dermatology
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- Malassezia Folliculitis versus Truncal Acne Vulgaris (Clinical and Histopathological Study)
- Novel acquisitions on the immunoprotective roles of the EGF receptor in the skin
- Acne Necrotica in Its Entirety: When It Starts, and After It Evolves
- Skin Manifestations of Rheumatological Diseases
- Probiotics in Dermatology: An Evidence-based Approach
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Poster Presentations
- Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections
- Off-label uses of retinoids in dermatology
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Subject Index
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Medical Dermatology
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Malassezia infection: is there any chance or necessity in refractory acne?
- SnapshotDx Quiz: January 2021
- Tufted Folikülit: Bir Olgu Sunumu
- Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update
- Compounding as a Current Therapeutic Option in Dermatology
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma
- Prophylaxis and Management of Skin Toxicities
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes
- The Non-Cosmetic Dermatological Use of Botulinum Neurotoxin